Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of ZymoGenetics, Inc.
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of ZymoGenetics, Inc. (“ZymoGenetics” or the “Company”) (NASDAQ:ZGEN) related to the Company’s agreement to be acquired by Bristol-Myers Squibb Company (“Bristol-Myers”). The proposed transaction is valued at approximately $885 million.
Under the terms of the definitive agreement entered into by the parties, a wholly owned subsidiary of Bristol-Myers has commenced a cash tender offer to purchase all of the outstanding shares of ZymoGenetics common stock for $9.75 per share. Shareholders holding approximately 37% of the outstanding shares of ZymoGenetics common stock have entered into agreements with Bristol-Myers to tender their shares in the offer. In addition, the merger agreement includes a provision under which ZymoGenetics has agreed not to solicit any competing offers for the Company. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by ZymoGenetics’ board of directors.
If you own shares of ZymoGenetics, if you have information or would like
to learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact Howard
G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
Toll Free at (888) 638-4847, or by email to
or visit our website at
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV